Letters
Modernising vaccine surveillance systems
HPV vaccine: adverse event signals were minimised or ignored
BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l4508 (Published 05 July 2019) Cite this as: BMJ 2019;366:l4508
- Manuel Martínez-Lavín, chief
- Rheumatology Department, National Institute of Cardiology, Juan Badiano 1, 14080 Mexico City, Mexico
- drmartinezlavin{at}gmail.com
Chandler discusses the difficulties in the pharmacovigilance of HPV vaccines due to the non-specific nature of dysautonomia symptoms reported to surveillance agencies.1
In our critical review, we found that serious adverse event signals were already present in the largest randomised trials of HPV vaccines. These signals were ignored or minimised.2 The group of 2881 women injected with the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.